Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab
<p><strong>Objectives</strong></p><p>Treat to target recommendations for PsA state that the target of treatment should be remission or, at the very least, low disease activity. Different clinical indexes have been proposed to define these disease states including the mi...
المؤلفون الرئيسيون: | Coates, L, Rahman, P, Psaradellis, E, Rampakakis, E, Osborne, B, Lehman, A, Nantel, F |
---|---|
التنسيق: | Journal article |
منشور في: |
Oxford University Press
2018
|
مواد مشابهة
-
Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry
حسب: Emmanouil Rampakakis, وآخرون
منشور في: (2020-08-01) -
Golimumab for the treatment of psoriatic arthritis
حسب: H Yang, وآخرون
منشور في: (2011-05-01) -
Golimumab in the treatment of psoriatic arthritis: efficacy and safety
حسب: Tatiana Viktorovna Korotaeva, وآخرون
منشور في: (2015-09-01) -
Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
حسب: Proton Rahman, وآخرون
منشور في: (2020-09-01) -
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
حسب: M. Rossini, وآخرون
منشور في: (2015-03-01)